Suboxone Tooth Decay Lawsuit
- Last Updated: December 19th, 2024
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Key takeaways:
- The Suboxone tooth decay lawsuit alleges that manufacturer Indivior failed to warn patients and healthcare providers about serious dental risks, leading to thousands of consolidated cases in multidistrict litigation.
- The FDA identified 305 dental injury cases linked to Suboxone use, with 37% of patients experiencing damage to multiple teeth and 23.3% requiring tooth extractions, even in patients with no prior dental issues.
- Patients who used Suboxone as prescribed and suffered dental damage may be eligible for compensation through the MDL depending on factors such as the severity of injuries, medical costs, etc.
Overview of the Suboxone Tooth Decay Lawsuit
The Suboxone tooth decay lawsuit against Indivior, the manufacturer of Suboxone, has been consolidated into a multi-district litigation within the United States District Court for the Northern District of Ohio.
The Suboxone Tooth Decay MDL consolidates thousands of individual injury claims, alleging that Indivior failed to adequately warn patients seeking opioid addiction treatment and healthcare providers about the oral health risks associated with Suboxone.
On this page, we’ll provide an overview of the Suboxone tooth decay lawsuit, dental injuries identified in the FDA Adverse Event Reporting System (FAERS), eligibility criteria to file in the Suboxone tooth decay MDL 3092, and much more.
Suboxone Tooth Decay Lawsuit Allegations
Suboxone lawyers are actively investigating claims that patients who used Suboxone film have suffered significant dental damage, including tooth decay, erosion, and even tooth loss, allegedly due to the product’s acidic formulation and insufficient warnings provided by the manufacturer.
Allegations in the Suboxone tooth decay lawsuit include, but are not limited to:
- Failure to Warn: Defendants were aware of the dental risks associated with prescription Suboxone film but did not adequately inform patients or healthcare providers.
- Acidic Formulation Leading to Dental Damage: The design of Suboxone film is inherently acidic, causing dental erosion and decay when dissolved in the mouth.
- Insufficient Testing and Warnings: The testing conducted on the Suboxone film was inadequate, and the warnings regarding potential dental problems were insufficient.
TruLaw is currently accepting clients for the Suboxone tooth decay lawsuit.
If you or a loved one were prescribed Suboxone to treat opioid addiction and suffered severe tooth decay, you may qualify to seek compensation.
Contact us using the chat on this page to receive an instant case evaluation, which can determine your eligibility to file a claim in the Suboxone tooth decay lawsuit today.
Table of Contents
Lawsuit Updates
-
December 2024 Updates:
December 19, 2024
This week marked a significant development in the Suboxone mass tort litigation, as oral arguments were heard for the Defendants’ Motion to Dismiss.
The motion, filed in June 2024, revolves around the preemption defense, a common strategy in mass tort cases involving FDA-approved drugs.
In such cases, manufacturers often argue that they cannot be held accountable under state laws because their products were federally approved, particularly by the FDA.
The Defendants contend that the FDA’s approval of Suboxone and the absence of confirmed adverse event reports restricted their ability to modify the label and warn about the possible risk of tooth decay.
The Plaintiffs, however, assert that FDA approval does not absolve manufacturers from their continuing obligation to monitor, report, and disclose risks, including those related to tooth decay, linked to Suboxone usage.
Judge Calabrese is anticipated to rule on the Motion to Dismiss before the next Case Management Conference, scheduled for January 14, 2025.
If the Plaintiffs succeed, the case could proceed to discovery and potential trials, advancing claims for compensation due to Suboxone-related dental injuries.
If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.
December 4, 2024
Oral arguments for a motion to dismiss over 11,000 Suboxone tooth decay lawsuits are set for December 16.
Indivior, the manufacturer of Suboxone, contends that federal law preempted its ability to update the drug’s warning labels until June 2022.
The lawsuits claim that Suboxone, a sublingual film used for opioid addiction treatment, can degrade tooth enamel, causing dental decay, cavities, oral infections, and tooth loss.
Plaintiffs allege that Indivior was aware—or should have been aware—of these risks but failed to adequately warn users or provide guidance to prevent these issues.
The cases have been consolidated into multidistrict litigation (MDL) before U.S. District Judge Philip Calabrese in the Northern District of Ohio for coordinated pretrial proceedings.
Following a November status conference, Judge Calabrese will hear the oral arguments on December 16.
The court has requested a joint report by December 12 to identify any remaining issues for review.
Should the motion to dismiss be denied, the MDL will likely advance to the selection of bellwether cases, which could serve as representative trials for the broader litigation.
These early trials may influence settlement negotiations and determine potential compensation amounts for the unresolved lawsuits.
If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.
December 2, 2024
The Judicial Panel on Multidistrict Litigation (JPML) reported 678 case filings in the Suboxone Tooth Decay lawsuit in November.
By December, the filings rose to 716, reflecting an increase of 38 cases.
This lawsuit centers on claims that Suboxone, an opioid addiction treatment, caused serious dental problems such as tooth decay and loss, with plaintiffs alleging that the manufacturer failed to adequately warn about these risks.
The rise in filings may be attributed to increased awareness among patients and healthcare providers about the link between Suboxone use and dental damage.
The litigation continues to grow as more plaintiffs come forward, seeking accountability for the alleged harm caused by the medication.
If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.
-
November 2024 Updates:
The Suboxone Tooth Decay Lawsuit centers on allegations that Suboxone, a drug used to treat opioid addiction, has led to severe dental problems such as extensive tooth decay, erosion, and loss.
Plaintiffs claim that Indivior, the drug’s manufacturer, failed to properly inform users about the potential risk of dental damage as a side effect of Suboxone.
In October, 674 cases had been filed related to Suboxone tooth decay claims, which increased slightly to 678 by November, adding 4 new cases.
This gradual rise suggests that more users are becoming aware of the dental risks tied to prolonged Suboxone use.
The drug’s impact on dental health may lead to painful, costly procedures, which significantly affects the well-being of individuals relying on Suboxone for opioid addiction management.
If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.
-
October 2024 Updates:
October 4, 2024
The Suboxone Lawsuit is ongoing.
A multi-day status conference for the Suboxone Tooth Decay Lawsuit commenced on October 4, 2024, uniting plaintiffs, defendants, and the MDL judge overseeing Suboxone dental injury cases.
The goal is to finalize protocols for the upcoming discovery phase and early bellwether trials.
Over 11,000 claims allege that Suboxone, a sublingual film medication, led to severe dental issues like tooth decay and enamel damage, citing insufficient warnings from its manufacturer, Indivior.
A central focus of this conference is the development of a detailed census protocol requiring plaintiffs to provide comprehensive information about their injuries.
This census will help the court identify cases representative of the broader claims, aiding in the selection of cases for the initial bellwether trials.
These trials aim to gauge jury responses to evidence related to Suboxone’s alleged dental risks.
In response to increasing reports of dental issues, the FDA updated Suboxone’s labeling in June 2022 to include warnings about potential dental damage.
Plaintiffs argue that had Indivior issued earlier warnings and provided proper usage guidelines, many users could have avoided severe dental injuries.
Conference discussions include the steps needed for gathering additional case details, medical records, and adverse event reports.
These early trials will involve extensive discovery, including expert testimony on the link between Suboxone use and dental harm.
If you or a loved one used Suboxone and suffered severe tooth decay, you may qualify to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Suboxone Lawsuit and connect with a Suboxone lawyer instantly.
October 1, 2024
The Suboxone Tooth Decay Lawsuit centers on claims that the drug, used to treat opioid addiction and opioid use disorder (OUD), leads to serious dental issues, including tooth decay, loss, and other oral health complications.
Plaintiffs argue that the manufacturers of Suboxone did not provide sufficient warnings about the drug’s side effects, particularly its potential to cause significant dental damage.
In both September and October, the Judicial Panel on Multidistrict Litigation (JPML) reported 674 active Suboxone tooth decay lawsuits.
Users of Suboxone have reported severe dental problems, such as rapid tooth decay and tooth loss, requiring expensive treatments like root canals, dentures, or implants.
If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.
-
September 2024 Updates:
September 11, 2024
The Suboxone Lawsuit is ongoing. In a recent update on the Suboxone MDL, an Ohio federal judge dismissed Indivior PLC and two Reckitt Benckiser entities from the lawsuits alleging that Suboxone, a treatment for opioid addiction, caused dental decay.
U.S. District Judge J. Philip Calabrese issued the dismissal following an agreement reached between the parties involved.
The claim filed by plaintiff Ryan Bennett was dismissed with prejudice, meaning it cannot be refiled, while other claims in the MDL were dismissed without prejudice, allowing those cases to potentially be brought again in the future.
The litigation focuses on allegations that the companies failed to warn consumers about the acidic properties of Suboxone’s dissolvable film, which could damage teeth.
Although Indivior and Reckitt Benckiser have been dismissed from the MDL, the litigation continues against other defendants, including Aquestive Therapeutics Inc.
The MDL, which was consolidated in February 2024, now includes claims from multiple states.
This follows Indivior’s earlier settlement of antitrust claims in a separate Suboxone case.
If you or a loved one took Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify for a Suboxone Lawsuit and to get in touch with a Suboxone lawyer.
September 9, 2024
The Suboxone Lawsuit is ongoing.
The Suboxone Lawsuit, which saw a surge of activity earlier this year due to concerns about the statute of limitations, has been relatively quiet recently.
However, this is expected to change as we near the end of 2024.
Litigation is expected to gain momentum as defendants are scheduled to produce key documents and custodial files that plaintiffs will likely receive before year-end.
A pivotal moment in the case will occur on October 4, 2024, when the oral argument for the Defendants’ Motion to Dismiss (MTD) based on preemption will take place.
If plaintiffs successfully challenge the MTD, the lawsuit will proceed rapidly, with the bellwether trial process likely being agreed upon, and defendants will start to receive case-specific disclosures.
This could mark a significant turning point in the Suboxone Tooth Decay Lawsuit, with substantial developments expected in the months ahead.
If you or a loved one took Suboxone and experienced severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TruLaw for a free consultation. Use the chatbot on this page to see if you qualify to file a Suboxone Lawsuit instantly.
September 1, 2024
The Suboxone Tooth Decay Lawsuit, which addresses claims that Suboxone use has resulted in severe dental problems, continues to see a slight rise in filings.
In August 2024, there were 673 active cases, which increased marginally to 674 by September 2024.
Plaintiffs in this lawsuit claim that Suboxone users have suffered from significant tooth decay despite maintaining proper dental hygiene, and they argue that the manufacturer did not provide sufficient warnings about these risks.
If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.
-
August 2024 Updates:
The Suboxone Lawsuit involves claims against the drug’s manufacturer regarding an increased risk of severe tooth decay and other dental injuries.
In July, there were 677 filings in the Suboxone lawsuit, which slightly decreased to 673 by August.
Suboxone, a medication used to manage opioid addiction, has been associated with severe tooth decay, including cavities, tooth loss, and other dental problems.
Many affected individuals have filed lawsuits against Indivior, alleging that the company failed to adequately warn about these dental risks, leading to significant health complications and financial burdens for dental treatments.
If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.
-
July 2024 Updates:
July 29, 2024
August 16 & 27, 2024: Key Submission Dates
Key dates for the Suboxone Tooth Decay Lawsuit are fast approaching.
Suboxone Lawsuits are advancing with submission dates in August 2024 and a potential settlement timeline extending into mid-2025.
The litigation is continuing to grow, and lawyers are still accepting new Suboxone claims.
In June 2024, there were 258 Suboxone Lawsuit filings reported by the JPML.
By July 2024, the number of Suboxone Lawsuits had increased to 677.
Key Submission Dates:
- Claim information and party proposals due on August 16 and 27, 2024.
- These documents are vital for progressing the litigation and may significantly impact the direction of the case.
Settlement Timeline:
- Settlement discussions are expected to extend into mid-2025.
- The earliest potential settlement by June 2025, pending resolution of ongoing issues within the litigation.
Tolling Agreement:
- Progress report due on August 1, 2024. The tolling agreement pauses the statute of limitations, allowing time for comprehensive case preparation.
If you or a loved one took Suboxone and subsequently suffered severe tooth decay, you may be eligible to take action and file a Suboxone Lawsuit.
Contact TruLaw for a free consultation.
Use the chatbot on this page to find out if you qualify to file a Suboxone Lawsuit and to get in touch with a licensed Suboxone lawyer.
July 17, 2024
The Suboxone Lawsuit is ongoing.
The number of Suboxone lawsuits has increased as more patients report severe tooth decay and other dental problems associated with the medication, seeking legal support from Suboxone Lawyers.
Suboxone Tooth Decay Lawsuits involve claims of dental injuries resulting from the use of the drug, a medication used for opioid addiction treatment.
The core arguments in the Suboxone Tooth Decay Lawsuits revolve around:
- Failure to Warn: Plaintiffs argue that the manufacturers did not provide adequate warnings about the risk of severe tooth decay associated with Suboxone.
- Negligent Design: Allegations include that the design of Suboxone contributes to an increased risk of dental problems, including tooth decay.
- Lack of Adequate Instructions: Many lawsuits claim that the manufacturers failed to provide proper instructions on how to minimize dental risks while using Suboxone.
In response to the increasing litigation, healthcare professionals recommend the following precautions for those using Suboxone:
- Maintain Oral Hygiene: Follow a strict oral hygiene routine, including brushing and flossing regularly.
- Regular Dental Check-Ups: Schedule frequent dental check-ups to monitor and address any early signs of tooth decay.
- Discuss with Your Doctor: Talk to your healthcare provider about the potential dental risks and ways to mitigate them while using Suboxone.
If you or a loved one has suffered from dental issues due to Suboxone, contact TruLaw for a free consultation.
The Suboxone lawsuit is ongoing.
The Suboxone lawsuit involves claims that the opioid addiction treatment drug Suboxone has caused severe dental issues, including tooth decay, tooth loss, and other dental problems.
This lawsuit seeks to hold the manufacturer accountable for these adverse effects.
In June, there were 258 Suboxone lawsuit filings.
By July, this number increased to 677.
Suboxone can cause significant dental problems, leading to tooth decay and tooth loss.
These issues have prompted more individuals to join the Suboxone lawsuit.
If you or a loved one has been negatively affected by suboxone, call today for a free consultation.
You can also use the chatbot on this page for an instant case evaluation.
-
June 2024 Updates:
June 20, 2024
Recently, more than 9,600 individuals have joined a mass lawsuit against the producers of Suboxone, filing their claims shortly before a crucial deadline that might have affected eligibility in numerous states.
Suboxone, a medication used to treat opioid addiction, has been associated with significant dental problems, including tooth decay and irreversible damage.
This drug combines buprenorphine and naloxone and is widely prescribed to alleviate symptoms of opioid withdrawal.
Initially approved in tablet form in 2002, its sublingual film variant was launched around 2012.
The plaintiffs claim this film version was created to stave off generic competition and did not adequately warn of dental health risks.
It was not until June 17, 2022, after multiple reports of tooth loss, that the FDA mandated a warning for tooth decay.
As we near the second anniversary of this FDA warning update, there are already about 500 Suboxone lawsuits pending in federal courts.
These cases are under the supervision of U.S. District Judge Philip Calabrese in the Northern District of Ohio, grouped together in a multidistrict litigation (MDL) initiated in February 2024 to facilitate coordinated discovery and pretrial activities.
Judge Calabrese is expected to implement a bellwether process, selecting specific cases for early trial that will help guide subsequent settlement discussions.
If you or someone you know has experienced serious tooth decay after using Suboxone, you might be eligible to join the Suboxone Lawsuit.
Contact us for a complimentary consultation, or use the chatbot on this page for an instant eligibility assessment for the Suboxone Tooth Decay Lawsuit.
June 14, 2024
The Suboxone Tooth Decay Lawsuit is ongoing, and our lawyers are accepting new clients.
The U.S. District Judge overseeing the consolidated Suboxone dental decay lawsuits has initiated a Leadership Development Committee (LDC) to streamline case management and enhance legal representation across the MDL.
This committee is part of the mass tort litigation process, focusing on the widespread claims that Suboxone film causes severe dental decay, a side effect previously undisclosed by the drug’s manufacturer.
Suboxone is a medication used to treat opioid addiction, but the sublingual film version of the drug introduced in 2012 has been linked to significant dental health issues, including enamel erosion, tooth decay, cavities, oral infections, and loss of teeth.
It wasn’t until June 17, 2022, that the FDA mandated warnings about the risk of tooth decay on the medication’s labeling, spurred by numerous patient complaints.
Plaintiffs allege that an earlier warning could have prevented irreversible dental damage.
Approximately 350 product liability lawsuits are pending in the MDL, with numbers expected to surge as the two-year anniversary of the label update approaches, signaling a potential deadline for new claims.
These cases have been centralized in the Northern District of Ohio under Judge Philip Calabrese for coordinated pretrial proceedings.
If you or a loved one used Suboxone and suffered severe tooth decay, you may be eligible to file a Suboxone Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Suboxone Tooth Decay Lawsuit instantly.
June 3, 2024
The Suboxone Tooth Decay Lawsuit is actively proceeding, and our attorneys are currently welcoming new clients.
According to the most recent updates from the Judicial Panel on Multidistrict Litigation (JPML), 258 lawsuits have been grouped into the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation.
These lawsuits claim that Suboxone, particularly when used as a sublingual film or tablet, significantly increases the risk of severe tooth decay due to the prolonged exposure of teeth to substances that promote decay.
The litigation consolidates these claims into a single federal court, focusing on the severe dental issues allegedly caused by Suboxone.
If you or someone you know has experienced serious tooth decay after using Suboxone, you might be eligible to join the Suboxone Lawsuit.
Contact us for a complimentary consultation, or use the chatbot on this page for an instant eligibility assessment for the Suboxone Tooth Decay Lawsuit.
-
May 2024 Updates:
May 13, 2024:
The Suboxone Tooth Decay Lawsuit continues to progress.
Plaintiffs are advocating for a tolling agreement in this multi-district litigation (MDL) to pause the statute of limitations, allowing more claims for dental injuries from Suboxone.
Since November 2023, the necessity of this agreement has been a focal point for effective litigation management.
As of May 2024, there are nearly 500 pending cases in the lawsuit. Without a tolling agreement, there’s a risk of an overflow of potentially unapproved claims, which could complicate the MDL’s objective to streamline these cases.
Defendants have consistently rejected the tolling agreement, a move plaintiffs see as a tactic to increase litigation challenges, possibly deterring weaker claims and adding complexity to the process.
Controversy also surrounds the Suboxone warning label, updated on June 17, 2022, to include risks of dental decay and tooth erosion.
Plaintiffs propose that the court should require defendants to respond to each complaint.
Impending court decisions will likely influence the lawsuit’s trajectory, affecting strategies of both parties involved.
May 1, 2024:The Suboxone Lawsuit is currently active.
There are now 205 lawsuits consolidated in the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, as reported in the latest JPML filings.
This represents a significant increase, with 161 cases added to the litigation in the past month alone, up from just 44 cases on April 1st.
The lawsuits allege that Suboxone’s formulation, particularly when used as a sublingual film or tablet, leads to prolonged exposure of the teeth to substances that can cause decay.
The Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation centralizes claims that Suboxone is linked to severe tooth decay in a single federal court.
If you or someone you know has experienced severe tooth decay after using Suboxone, you might be eligible to participate in a Suboxone Lawsuit.
Contact us for a free consultation.
Additionally, you can instantly check if you qualify for the Suboxone Tooth Decay Lawsuit by using the chatbot on this page.
-
April 2024 Updates:
As of April 1st, the Judicial Panel on Multidistrict Litigation (JPML) reports a decrease in the number of pending Suboxone Lawsuits to 44, down from 51 on March 1st.
These lawsuits have been filed by individuals who used Suboxone for opioid addiction treatment and subsequently suffered severe tooth decay and other dental injuries.
In 2022, the FDA mandated that manufacturers include warning labels on Suboxone packaging to alert consumers about potential dental issues.
However, claims suggest that many users were not adequately warned about these risks prior to this mandate.
If you or a loved one has been affected by Suboxone contact us today for a free consultation.
Alternatively, use the chatbot on this page for an instant Suboxone Tooth Decay lawsuit evaluation.
-
March 2024 Updates:
March 26, 2024:
The Suboxone Tooth Decay Lawsuit continues, and our attorneys are open to representing new clients.
The United States District Court for the Northern District of Ohio has facilitated the submission of dental injury lawsuits related to Suboxone film by enabling plaintiffs to directly file their cases in this court within the broader framework of Multidistrict Litigation (MDL) No. 3092.
Suboxone, a medication prescribed for opioid addiction treatment, combines buprenorphine to lessen withdrawal symptoms with naloxone to prevent misuse.
Risks associated with Suboxone, especially the versions that dissolve orally, include significant tooth decay, cavities, and tooth loss.
This direct filing system expedites the legal process by eliminating the requirement for lawsuits to be transferred from various jurisdictions to this centralized court.
While plaintiffs have the choice to file their lawsuits directly in this MDL, it is not mandatory.
Lawyers nationwide are able to represent their clients in this MDL without the need for special authorization or additional fees, making the process more streamlined for plaintiffs.
Plaintiffs in their submissions are encouraged to propose a trial venue that has personal relevance to their case, such as their residence, the location where Suboxone was prescribed, or where it was used.
While this does not ensure the trial will occur in the proposed location, it aids in the organization of cases within the MDL structure.
This initiative by the Northern District of Ohio aims to make the legal process more accessible and efficient for those pursuing claims for dental damages allegedly caused by the use of Suboxone film and tablets that dissolve in the mouth.
If you or someone you know has experienced dental problems, tooth decay, oral infections, or other dental injuries after using Suboxone, you might be eligible to participate in the Suboxone Tooth Decay Lawsuit.
For a complimentary consultation, contact us today, or use the chatbot on this webpage for an instant assessment of your eligibility for the Suboxone Lawsuit.
March 19, 2024:
The Suboxone Litigation continues, and our legal team is actively taking on new cases.
As of March 19th, the number of cases consolidated into the Multidistrict Litigation (MDL) focusing on Suboxone-related tooth decay has reached 51.
MDLs are essential for handling multiple lawsuits that have similar facts, especially in areas like pharmaceuticals, product defects, and complex legal matters, efficiently.
This consolidation process for the Suboxone cases facilitates the streamlining of the discovery process, the sharing of evidence, and the speeding up of individual lawsuits.
The formation of an MDL for Suboxone Lawsuits is a significant step in their handling and potential settlement.
It enables the pooling of resources, which supports a stronger legal approach bolstered by thorough expert analyses and investigative work.
Those who have suffered from dental problems due to Suboxone use now have a chance to seek legal recourse and may join a collective effort to obtain compensation.
The creation of this MDL highlights a dedication to securing justice for individuals who have endured dental harm as a side effect of their treatment for addiction.
If you or a loved one has faced serious dental issues as a consequence of using Suboxone, you may have the right to pursue legal action.
By using the chatbot on this page, you can quickly assess whether you qualify to file a Suboxone Lawsuit and get connected with a specialized Suboxone lawyer.
-
February 2024 Updates:
The Suboxone Litigation remains active, with our legal team continuing to accept new cases.
The Northern District of Ohio now serves as the consolidation point for the Suboxone Tooth Decay Lawsuit, as determined by the Judicial Panel on Multidistrict Litigation (JPML).
According to the latest JPML updates, eleven lawsuits have been merged into this new Multi-District Litigation (MDL).
MDLs in the United States are established to efficiently manage multiple civil cases that share common legal issues, facts, or defendants.
This legal mechanism is particularly useful when a large number of lawsuits are filed across various jurisdictions, sharing a commonality such as tooth decay claims from Suboxone usage.
These cases are then combined in a single federal district court to undergo pretrial processes together.
The goal of an MDL is to streamline the legal process by centralizing discovery efforts, minimizing repetitive tasks, and ensuring uniform decisions on pivotal legal matters.
For individuals affected by dental problems attributed to Suboxone, the establishment of an MDL offers a pathway to collectively seek compensation through mass tort litigation.
The creation of an MDL for Suboxone Tooth Decay marks an important move towards achieving justice for individuals who have experienced tooth decay or other dental injuries as a result of using this opioid treatment medication.
If you or someone you care about has endured severe tooth decay following Suboxone use, you might have grounds to pursue legal action and file a lawsuit.
The chatbot on this page can assist in determining your eligibility to file a Suboxone Lawsuit and connect you with a qualified Suboxone attorney.
The Suboxone Tooth Decay Lawsuit is ongoing.
-
October 2023 Updates:
Indivior has reached a $385 million settlement to resolve claims from drug wholesalers in the U.S., accusing the company of illegally hindering generic versions of its opioid addiction medication, Suboxone.
This agreement concludes protracted legal disputes over Suboxone, adding to previous settlements of $102.5 million in June with U.S. states and $30 million in August to address a class action from health plans.
The settlement avoids a trial that was set for October 30, involving around 70 Suboxone purchasers.
Suboxone was approved in the U.S. in 2002, with Indivior enjoying exclusive rights until 2009.
The legal challenge centered on allegations that Indivior transitioned to a film version of Suboxone to unlawfully maintain its market dominance as generics were poised to introduce more affordable tablet options.
In addition to this settlement, Indivior agreed in 2020 to a $600 million payment to settle charges by the U.S. government related to the fraudulent marketing of Suboxone.
Opioid-related overdoses have been implicated in more than 900,000 deaths in the U.S. since 1999, as reported by the CDC.
Mark Crossley, CEO of Indivior, stated that this settlement provides more predictability for the company’s stakeholders and emphasized that the agreement does not include an admission of liability.
The settlement awaits approval from the United States District Court for the Eastern District of Pennsylvania, with the payment anticipated to occur the following month.
If you or someone close to you has experienced severe tooth decay after using Suboxone, you might be entitled to pursue a lawsuit.
The chatbot on this page can assist in determining your eligibility for a Suboxone Lawsuit and connect you with a qualified attorney specializing in Suboxone cases.
FAQ: What is Suboxone?
Suboxone is a prescription medication that combines buprenorphine and naloxone, primarily used to treat opioid use disorder (OUD).
The drug is administered as a sublingual film strip that dissolves under the tongue to reduce withdrawal symptoms associated with opioid dependence.
The (2) two active ingredients in Suboxone are:
- Buprenorphine: A partial opioid agonist that helps reduce cravings and withdrawal symptoms without producing the intense euphoria associated with full opioids.
- Naloxone: An opioid antagonist that precipitates withdrawal symptoms to deter misuse.
The sublingual buprenorphine-naloxone is intended to be part of a comprehensive treatment plan for doctors to gradually reduce the dosage over time until patients are completely weaned off the drug in combination with counseling and therapy.
An alarming amount of cases describe severe oral health issues in patients with no reported prior history of dental problems.
How Suboxone Causes Tooth Decay
Suboxone’s acidic composition creates significant oral health risks during its required 5-10 minute sublingual dissolution period.
The medication’s dual mechanisms of direct acid exposure and induced xerostomia (dry mouth) can significantly impact dental health.
This combination creates an environment particularly conducive to tooth decay and enamel erosion.
The following factors contribute to Suboxone-related dental complications:
- Direct Acid Exposure: Requires a minimum of 5-10 minutes of continuous acid contact during dissolution; prolonged exposure can occur when proper mouth rinsing is omitted, and repeated daily acid exposure is common with ongoing treatment.
- Xerostomia Effects: Reduced saliva production, leading to diminished natural buffering of oral pH and decreased natural cleansing of the oral cavity.
- Enamel Impact: Progressive erosion of the protective enamel layer, resulting in increased vulnerability to bacterial invasion and a heightened risk of cavity formation and structural damage.
Proper oral hygiene protocols, including post-dissolution mouth rinsing, are often overlooked in patient education for patients on Suboxone therapy.
Reduced saliva production and repeated acid exposure create a particularly challenging environment for maintaining dental health.
Regular dental monitoring and preventive care are essential to long-term Suboxone treatment management.
If you or a loved one were prescribed Suboxone to treat opioid addiction and suffered severe tooth decay, you may qualify to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation determining your eligibility to file a claim in the Suboxone tooth decay lawsuit today.
Dental Injuries Identified in the FDA Adverse Event Reporting System (FAERS)
In January 2022, the U.S. Food and Drug Administration (FDA) issued a warning about dental problems associated with buprenorphine medications dissolved in the mouth, such as Suboxone.
The FDA identified 305 cases of dental issues, including tooth decay, cavities, oral infections, and tooth loss, of which 131 were classified as serious.
They also acknowledged that this number is likely underestimated, as not all cases are reported, and many patients may not associate their dental problems with buprenorphine use.
The majority of these cases occurred in patients using the medication for opioid use disorder (OUD).
FDA Analysis of Buprenorphine Medications
The FDA’s analysis of buprenorphine medications underscores an array of dental complications linked to the transmucosal form of this drug, which includes tablets and films dissolved in the mouth.
These adverse dental effects include rapid decay, dental abscesses, and tooth fractures.
The analysis reveals that even patients without a history of dental issues are at risk, with some cases of dental injury manifesting as soon as two weeks after beginning treatment.
Analysis of the documented cases reveals the following data:
- The average patient age was 42 years, with documented instances starting from age 18;
- 37% of patients experienced damage to two or more teeth;
- 23.3% of cases necessitated tooth extraction procedures;
- 8.5% of affected patients had no prior dental issues; and
- Treatments often involve root canals, crowns, implants, or other dental surgeries.
Healthcare professionals provided extensive documentation as evidence supporting the severity of the Suboxone tooth decay claims.
The median timeframe for diagnosis was approximately (2) two years after initiating treatment.
Initial oral complications were observed in some patients as early as (2) two weeks after beginning buprenorphine therapy.
According to the FDA, the benefits of buprenorphine in OUD management continue to outweigh these risks.
However, dental care providers and patients are urged to adopt specific preventive measures, such as regular dental checkups and following post-dissolution rinsing routines, to help reduce the likelihood of severe dental outcomes.
Additional Oral Health Risks Associated With Suboxone
Suboxone, a combination of buprenorphine and naloxone, is also associated with substantial oral health risks when dissolved in the mouth.
The acidic nature of these medications, combined with the method of administration, creates an environment conducive to enamel erosion and bacterial growth, both of which accelerate tooth decay.
The following are specific concerns associated with Suboxone use:
- Enamel erosion: Increased risk due to acidity and prolonged exposure
- Bacterial growth: The mouth’s altered pH fosters conditions for oral bacteria
- Preventive practices: Rinsing with water post-dose, delaying tooth brushing by one hour
- Long-term effects: Potential for multiple tooth extractions, crowns, or implants due to significant decay
The FDA advises Suboxone patients to follow stringent dental hygiene practices and maintain consistent dental checkups to detect and address early signs of decay.
If you or a loved one were prescribed Suboxone to treat opioid addiction and suffered severe tooth decay, you may qualify to seek compensation.
Contact us using the chat on this page to receive an instant case evaluation, which can determine your eligibility to file a claim in the Suboxone tooth decay lawsuit today.
Do You Qualify for the Suboxone Tooth Decay Lawsuit?
Dental problems linked to Suboxone use can be life-changing for affected individuals, significantly impairing both oral health and overall quality of life.
The development of severe dental issues from Suboxone, such as tooth decay or tooth loss, often necessitates extensive and costly treatments, which can add a financial burden to the physical and emotional stress already experienced by patients.
For many in recovery from opioid use disorder, the added expense of critical dental care may be financially overwhelming, preventing them from accessing necessary treatments.
If you have experienced tooth decay, tooth loss, or other dental problems after using Suboxone, you may be eligible to file a Suboxone lawsuit.
Contact TruLaw for a free consultation, or use the chatbot on this page to find out instantly if you qualify to file a Suboxone lawsuit.
Suboxone attorneys can guide you through the legal process, helping you gather essential evidence and assess damages to build a strong case.
Gathering Evidence for Suboxone Lawsuits
Evidence is vital in personal injury and product liability lawsuits, as it helps establish the connection between Suboxone use and dental complications.
Working with an experienced lawyer can ensure all critical evidence is gathered and preserved, but you can also begin this step to strengthen your claim.
Important evidence in Suboxone lawsuits may include:
- Medical Records: Showing your Suboxone prescription, treatment duration, and any adverse effects documented by healthcare providers.
- Dental Health Records: Including detailed notes from dental professionals on the condition of your teeth and gums, diagnoses, and other dental injuries.
- Documentation of Suboxone Prescription: Records confirming that you were prescribed and regularly using Suboxone.
- X-ray Images of Damaged Teeth: X-rays provide clear visual proof of tooth damage, which is crucial for demonstrating the extent of dental injuries.
- Photos and Videos: Images or video documentation showing the progression of dental issues or the impact of treatments.
- Additional Evidence: Any other documents showing Suboxone use and subsequent dental health problems, such as treatment plans, medication lists, or dental cost breakdowns.
Collecting this evidence is essential in demonstrating how Suboxone led to severe dental issues, providing a factual basis for your claim and potentially influencing the compensation awarded.
Assessing Damages in Suboxone Lawsuits
Damages in Suboxone lawsuits refer to the total financial and personal losses sustained due to dental problems linked to Suboxone use.
Calculating these damages requires an experienced attorney who will work with you to evaluate each aspect of your claim and determine the compensation needed to address past, present, and future losses.
Potential damages in Suboxone lawsuits may include:
- Medical Bills (Past, Present, & Future): Compensation for all medical expenses related to dental issues, from initial diagnostics to ongoing treatments.
- Dental Bills: Coverage for the costs of restorative procedures, such as root canals, crowns, implants, or dentures.
- Lost Wages or Earning Ability: Recovery for income lost due to time off work and diminished earning potential if dental issues have impaired job performance.
- Pain and Suffering: Damages for physical discomfort, emotional distress, and psychological tolls related to ongoing dental complications.
- Lost Quality of Life: Compensation for reduced daily enjoyment or ability to engage in social, professional, or personal activities.
- Permanent Disability: In cases where dental injuries result in permanent limitations or disabilities.
- Emotional Damages: Compensation for the mental health impact of visible or painful dental injuries, especially if they affect self-confidence or social interactions.
- Other Compensatory and Punitive Damages: Depending on the case, punitive damages may apply if there’s evidence of manufacturer negligence, aiming to deter similar harm in the future.
Assessing these damages comprehensively can provide a more accurate picture of the claim’s value, offering plaintiffs the financial resources necessary to move forward while addressing the substantial effects of Suboxone-related dental damage.
If you or a loved one were prescribed Suboxone to treat opioid addiction and suffered severe tooth decay, you may qualify to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation, which can determine your eligibility to file a claim in the Suboxone MDL today.
Eligibility Criteria to File in the Suboxone Tooth Decay MDL 3092
Patients who have experienced significant dental damage linked to Suboxone use may be eligible to join the multi-district litigation (MDL) against its manufacturer.
The MDL aims to consolidate claims of individuals who have suffered from severe tooth decay, gum disease, or other oral health complications associated with sublingual Suboxone.
Eligible plaintiffs typically must demonstrate that they used Suboxone as prescribed, experienced dental injuries attributable to the medication, and incurred financial or personal losses due to these injuries.
An attorney specializing in MDL cases at TruLaw can help assess eligibility and guide potential plaintiffs through the filing process.
Types of Recoverable Damages in the Suboxone MDL
The Suboxone tooth decay litigation allows plaintiffs to seek compensation for various damages related to dental injuries and their impact on quality of life.
These recoverable damages provide financial relief for both the economic and non-economic consequences associated with severe dental health issues caused by Suboxone use.
Common types of recoverable damages in the Suboxone MDL include:
- Medical and Dental Expenses: This covers the cost of treatments required due to dental decay or gum disease, such as root canals, crowns, implants, or dentures.
- Future Dental Care: Compensation for anticipated costs related to ongoing dental treatments or preventive care needed due to permanent dental damage.
- Lost Wages or Earning Capacity: Provides for income lost due to dental pain, recovery time, or medical appointments and accounts for diminished earning potential in severe cases.
- Pain and Suffering: Addresses the physical discomfort and emotional distress caused by chronic dental issues, such as pain, self-consciousness, or difficulty eating.
- Impact on Quality of Life: Compensation for the reduction in daily enjoyment and social interactions due to dental injuries, especially when oral damage affects one’s appearance or confidence.
These damages reflect the significant toll that Suboxone-related dental complications can have on patients, aiming to support their recovery and mitigate the financial burden.
Steps to File a Suboxone Tooth Decay Lawsuit
Filing for the Suboxone tooth decay lawsuits involves several steps to ensure a thorough case evaluation and appropriate filing within the MDL framework.
Working with an attorney experienced in MDL cases can help streamline the process and maximize the potential for a successful outcome.
Here are the typical steps involved in filing a Suboxone tooth decay lawsuit:
- Consult an Attorney: Begin with a consultation to assess eligibility for the MDL, discuss potential damages, and understand the legal process involved in pursuing compensation.
- Collect Medical and Dental Records: Your attorney will help you gather documentation showing Suboxone use and dental treatments, including records of decay, extractions, crowns, or other necessary procedures.
- Document Financial and Personal Losses: Collect proof of expenses and personal impacts, such as medical bills, lost wages, or statements detailing the effect on daily life.
- File a Claim: Once the evidence is compiled, your attorney will submit the claim within the MDL, detailing the injuries and damages sustained.
- Participate in the Discovery Process: In MDL cases, discovery may involve sharing records, answering questions, or providing depositions. This phase aims to strengthen your case by establishing evidence of Suboxone-related harm.
- Negotiate or Proceed to Trial: Many MDL cases are resolved through settlement negotiations. If a fair settlement cannot be reached, the case may proceed to trial, where a judge or jury will determine the outcome.
By following these steps and working closely with a knowledgeable attorney, plaintiffs can build a strong case for compensation to address the lasting effects of Suboxone-related dental damage.
If you or a loved one were prescribed Suboxone and suffered tooth decay, you may qualify to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation, which can determine your eligibility to join others in filing for the Suboxone teeth lawsuits today.
Potential Suboxone Lawsuit Settlement Amounts
With increasing numbers of plaintiffs reporting severe dental injuries allegedly linked to Suboxone use, potential settlement amounts for Suboxone lawsuits are under scrutiny.
While the exact payout for individual cases remains uncertain, settlements in similar cases typically depend on factors such as the severity of dental issues, associated medical costs, lost wages, and the overall impact on quality of life.
Average Suboxone Lawsuit Settlement Amounts
No settlements have been reached in the Suboxone tooth decay lawsuits at this time.
However, legal experts estimate that average Suboxone settlement amounts could range between $10,000 and over $150,000 per claimant, depending on individual circumstances and the progression of the litigation.
These projections are based on settlements from similar product liability cases and should not be viewed as a guarantee of compensation.
For more information on your potential Suboxone lawsuit, contact TruLaw using the chat on this page to receive an instant case evaluation.
Though no specific average settlement amount has yet been established for dental-related Suboxone cases, prior settlements in pharmaceutical injury lawsuits suggest that settlements could vary widely based on individual circumstances.
Factors influencing the average settlement values in the Suboxone lawsuit include:
- Extent of Dental Damage: Severe cases requiring multiple procedures, such as extractions, implants, or full-mouth rehabilitation, will likely yield higher settlements.
- Impact on Daily Life: Cases where dental issues significantly hinder work, social life, or physical health can also drive higher settlement amounts.
- Ongoing Medical Needs: Plaintiffs needing continuous dental care or preventive measures due to permanent damage may receive greater compensation.
- Presence of Manufacturer Negligence: If proven, negligence or failure to warn consumers about Suboxone’s potential risks could result in higher compensatory or punitive damages.
Previous Lawsuits Against Indivior (Suboxone Manufacturer)
While Suboxone has played a pivotal role in treating opioid addiction, its history is fraught with legal challenges, primarily focused on misleading marketing practices and efforts to block generic competition.
These legal issues have led to significant financial penalties for Indivior, the manufacturer of Suboxone.
The following are key settlements that highlight the legal action taken against the company for various practices:
- October 2023: Indivior Inc. agreed to pay $385 million to resolve final Suboxone monopoly lawsuits. These lawsuits claimed that the company’s practices unlawfully restricted competition in the market.
- June 2023: Suboxone reached a $102.5 million settlement with 42 states to compensate states for inflated costs tied to restricted generic alternatives.
- May 2021: The Federal Trade Commission (FTC) announced that it returned nearly $60 million to consumers overcharged for Suboxone due to Indivior’s attempts to suppress generic competition.
- July 2019: The U.S. Justice Department secured a $1.4 billion settlement from Reckitt Benckiser Group, the former parent company of Indivior, addressing allegations of false marketing claims and safety misrepresentations.
These prior lawsuits demonstrate Indivior’s history of legal and regulatory challenges, with substantial penalties resulting from anti-competitive and allegedly misleading practices.
This pattern of litigation underscores the company’s ongoing legal vulnerability, a factor that could influence future settlements in dental injury cases as plaintiffs seek accountability for their injuries.
If you or a loved one were prescribed Suboxone to treat opioid addiction and suffered severe tooth decay, you may qualify to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation, which will determine your eligibility to file a claim in the Suboxone tooth decay lawsuit today.
TruLaw: Accepting Clients for the Suboxone Tooth Decay MDL
Suboxone tooth decay lawsuits are being filed by individuals across the country who were diagnosed with severe dental problems after taking Suboxone.
TruLaw is currently accepting clients for the Suboxone tooth decay lawsuit.
A few reasons to choose TruLaw for your Suboxone tooth decay lawsuit include:
- If We Don’t Win, You Don’t Pay: The Suboxone lawyers at TruLaw and our partner firms operate on a contingency fee basis, meaning we only get paid if you win.
- Expertise: We have years of experience handling pharmaceutical liability cases similar to the Suboxone tooth decay lawsuit, which helps us anticipate what we can expect to see in your case and the regulations we will be required to meet.
- Successful Track Record: TruLaw and our partner law firms have helped our clients recover billions of dollars in compensation through verdicts and negotiated settlements.
If you or a loved one suffered from severe dental problems after taking Suboxone sublingual films, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify to join others in filing a claim in the Suboxone MDL-3092 today.
Frequently Asked Questions
-
What is the Suboxone tooth decay lawsuit about?
The Suboxone tooth decay lawsuit alleges that Indivior, the manufacturer of Suboxone, failed to adequately warn patients and healthcare providers about serious dental risks associated with the medication.
The lawsuit has been consolidated into a multi-district litigation in the United States District Court for the Northern District of Ohio, combining thousands of individual injury claims.
-
How does Suboxone cause tooth decay?
Suboxone’s acidic composition creates significant oral health risks during its required 5-10 minute sublingual dissolution period, causing direct acid exposure and induced xerostomia (dry mouth).
This combination leads to progressive erosion of protective enamel and increased vulnerability to bacterial invasion, resulting in tooth decay and structural damage.
-
What types of dental injuries are associated with Suboxone use?
According to FDA analysis, patients using Suboxone have reported severe dental complications, including tooth decay, cavities, oral infections, and tooth extractions.
The FDA identified 305 cases of dental injuries, with 37% of patients experiencing damage to two or more teeth and 23.3% requiring tooth extraction procedures.
-
Is there a Suboxone class action lawsuit?
No, there is no Suboxone class action lawsuit.
Suboxone tooth decay cases have already been consolidated into multidistrict litigation (MDL), a process that combines similar individual lawsuits for more efficient court handling.
Unlike a class action, each case within an MDL remains separate, allowing plaintiffs to pursue compensation based on their specific injuries.
While some firms may use terms such as Suboxone Class Action Lawsuit or Suboxone Class Action MDL, these are inaccurate descriptions of the Suboxone MDL.
-
What is the statute of limitations for the Suboxone litigation?
The statute of limitations for a Suboxone lawsuit sets the deadline by which you must file a legal claim seeking compensation for dental health issues like severe dental decay allegedly caused by the medication.
This time limit varies depending on state law and when you discovered or should have reasonably discovered the connection between Suboxone and your tooth decay.
-
Who qualifies to file a Suboxone tooth decay lawsuit?
Patients who used Suboxone as prescribed and experienced significant dental damage, such as tooth decay, tooth loss, or other dental problems, may be eligible to file a lawsuit.
Qualified plaintiffs must demonstrate that their dental injuries are attributable to the medication and have resulted in financial or personal losses.
-
What types of compensation are available in Suboxone lawsuits?
Recoverable damages in Suboxone lawsuits include medical and dental expenses, future dental care costs, lost wages, and compensation for pain and suffering.
The settlement amounts vary based on the severity of dental issues, associated medical costs, and overall impact on quality of life.
-
What evidence is required for a Suboxone lawsuit?
Essential evidence includes medical records showing Suboxone prescription and treatment duration, dental health records documenting injuries and treatments, and x-ray images of damaged teeth.
Additional documentation may include photos, videos, treatment plans, and cost breakdowns demonstrating the extent of dental damage and related expenses.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Suboxone Lawsuit by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
